MI vs PBKS: Arjun Tendulkar gets smashed for 31 runs, joint most expensive over in IPL 2023
MI vs PBKS, IPL 2023: Arjun Tendulkar was smashed for 6, Wd, 4, 1, 4, 6, N4, 4 by Sam Curran and Harpreet Singh Bhatia in the 17th over.

Mumbai Indians pacer Arjun Tendulkar was given a reality check by Sam Curran and Harpreet Singh Bhatia as the Punjab Kings duo smashed 31 runs in the 16th over of Match 31 in the Indian Premier League (IPL) 2023 on Saturday.
Tendulkar was smashed for 6, Wd, 4, 1, 4, 6, N4, 4. It was the joint most expensive over in IPL 2023 after Gujarat Titans pacer Yash Dayal's 31-run over against Kolkata Knight Riders earlier this month.
Tendulkar came back for his final spell in the death overs after picking the wicket of Prabhsimran Singh in the the seventh over.
ALSO READ
Curran and Harpreet's 92-run partnership helped Punjab Kings recover from 118 for 4 to 149 for 4 after the Arjun Tendulkar over.
The 23-year-old finished with figures of 1 for 48 from three overs. He was taken off the attack by captain Rohit Sharma after getting smashed left, right and center.
"That over from Arjun changed the momentum in favour of Punjab," former India captain Anil Kumble said on air.
Punjab stage amazing recovery in Mumbai
Harpreet was eventually dismissed for 41 off 28 balls with four boundaries and a couple of sixes.
Stand-in captain Curran carried on to hit a half-century off just 26 balls and was finally dismissed for 55 by Jofra Archer in the penultimate over.
Punjab eventually posted 214 for 8 on the board thanks to the 96 runs the team's lower order smashed in the final 5 overs.
ALSO READ
RECENT STORIES
-
BEST Workers Union To March At Azad Maidan Today Over Pending Gratuity For 4,500 Retired Employees -
Boss Lady! Malaika Arora Suits Up As She Serves Boardroom Fashion With A Twist -
Telangana CM Revanth Reddy, Ministers Stage Dharna At Jantar Mantar Demanding Clearance Of 42% OBC... -
Shocking! 30-Year-Old Man's Body Found In Two Pieces On Railway Track In Indore -
Mumbai's KEM Hospital Lacks Haemophilia Medications, Forcing Costly Private Alternatives